Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
137.03
+1.44 (1.06%)
At close: Sep 26, 2025, 4:00 PM EDT
135.00
-2.03 (-1.48%)
After-hours: Sep 26, 2025, 7:28 PM EDT
Insmed Stock Forecast
Stock Price Forecast
The 16 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $146.81, which forecasts a 7.14% increase in the stock price over the next year. The lowest target is $109 and the highest is $240.
Price Target: $146.81 (+7.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 8 | 9 | 9 | 9 | 9 | 9 |
Buy | 8 | 8 | 8 | 8 | 8 | 7 |
Hold | 0 | 0 | 0 | 0 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 16 | 17 | 17 | 17 | 19 | 18 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Maintains $125 → $172 | Strong Buy | Maintains | $125 → $172 | +25.52% | Sep 8, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $140 → $171 | Buy | Maintains | $140 → $171 | +24.79% | Sep 3, 2025 |
Morgan Stanley | Morgan Stanley | Hold Maintains $126 → $144 | Hold | Maintains | $126 → $144 | +5.09% | Aug 21, 2025 |
JP Morgan | JP Morgan | Buy Maintains $111 → $135 | Buy | Maintains | $111 → $135 | -1.48% | Aug 20, 2025 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 20, 2025 |
Financial Forecast
Revenue This Year
479.90M
from 363.71M
Increased by 31.95%
Revenue Next Year
1.08B
from 479.90M
Increased by 125.46%
EPS This Year
-5.62
from -5.57
EPS Next Year
-4.01
from -5.62
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 523.1M | 1.5B | |||
Avg | 479.9M | 1.1B | |||
Low | 430.5M | 837.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 43.8% | 214.9% | |||
Avg | 31.9% | 125.5% | |||
Low | 18.4% | 74.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -5.20 | -2.49 | |||
Avg | -5.62 | -4.01 | |||
Low | -5.99 | -9.36 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.